The Neurotech Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region.
Growing Number of Elderly Populations with Neurological Disorders
The rapidly growing ageing population base suffering from neurological diseases will be a pivotal factor driving the market growth. Neurological disorders such as Alzheimer’s, dementia, Parkinson’s disease and chronic back & limb pain are most likely to affect people after 65 years of age. In such conditions using neurotech device therapies plays a pivotal role in treating these disorders. For instance, spinal cord stimulation (SCS) is an effective treatment for chronic back & limb pain. Also, failed back surgery syndrome (FBSS), peripheral neuropathic pain and residual pain after joint replacement in the elderly can be treated with spinal cord stimulators. The rising geriatric population will create such scenarios for market expansion.Lack of Resources Serving to the Needs of Patients with Neurological Disorders
Lack of skilled healthcare practitioners and availability of high-technology equipment is anticipated to hamper market growth over the forecast period. Furthermore, inadequate access to universal mental healthcare services will pose as a major challenge for market expansion. The shortage of critical resources is grave in underdeveloped regions and neglected groups that do not have access to new treatment options and improved technologies. In most of the low and middle-income countries, there is shortage of skilled healthcare staff and basic neurological diagnostic services. Lack of authentic information and switching to alternative forms of treatment options delay the treatment.What Questions Should You Ask before Buying a Market Research Report?
- How is the Neurotech Devices Market evolving?
- What is driving and restraining the Neurotech Devices Market?
- How will each Neurotech Devices submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each Neurotech Devices submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading Neurotech Devices Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Neurotech Devices development projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of Neurotech Devices development projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Neurotech Devices Market?
- Where is the Neurotech Devices Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Neurotech Devices Market today, and over the next 10 years:
- Our 330-page report provides 131 tables and 182 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, the impact of rising neurotech devices prices and recent developments.
Segments Covered in the Report
By Product
- Neurostimulation
- Deep Brain Stimulator
- Gastric Electric Stimulator
- Spinal Cord Stimulator
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Transcutaneous Electrical Nerve Stimulation
- Neuroprostheses
- Neurosensing
- Neurorehabilitation
By Conditions
- Pain Management
- Cognitive Disorders
- Epilepsy
- Urinary and Fecal Incontinence
- Hearing Conditions
- Parkinson’s Disease
- Depression
- Sleep Disorders
- Essential Tremor
- Others
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Homecare Facilities
- Others
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- Abbott Laboratories
- Advanced Bionics AG (Sonova)
- Boston Scientific Corporation
- BrainCo, Inc
- Cochlear Limited
- ElectroCore Inc
- Helbling Holding AG
- Innovative Health Solutions, Inc
- LivaNova PLC
- Medtronic
- MicroTransponder
- Natus medical Incorporated
- Neuronetics, Inc.
- Nihon Kohden Corporation
- Parasym Ltd.
- Synapse Biomedical
- tVNS Technologies GmbH (Cerbomed)
How will the Neurotech Devices Market, 2023 to 2033 report help you?
In summary, this 330-page report provides you with the following knowledge:- Revenue forecasts to 2033 for Neurotech Devices Market, 2023 to 2033 Market, with forecasts for product, conditions, end-use, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the Neurotech Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles of the major companies involved in the Neurotech Devices Market, 2023 to 2033.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Neurotech Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.Table of Contents
1 Report Overview
3 Market Overview
4 Neurotech Devices Market Analysis by Product
5 Neurotech devices market Analysis by Conditions
6 Neurotech devices market Analysis by End use
7 Neurotech Devices Market Analysis by Region
8 North America Neurotech Devices Market Analysis
9 Europe Neurotech Devices Market Analysis
10 Asia Pacific Neurotech Devices Market Analysis
11 Latin America Neurotech Devices Market Analysis
12 MEA Neurotech Devices Market Analysis
13 Company Profiles
14 Conclusion and Recommendations
Companies Mentioned
- Abbott Laboratories
- Advanced Bionics AG (Sonova)
- Boston Scientific Corporation
- BrainCo, Inc
- Cochlear Limited
- ElectroCore Inc
- Helbling Holding AG
- Innovative Health Solutions, Inc
- LivaNova PLC
- Medtronic
- MicroTransponder
- Natus medical Incorporated
- Neuronetics, Inc.
- Nihon Kohden Corporation
- Parasym Ltd.
- Synapse Biomedical
- tVNS Technologies GmbH (Cerbomed)
- Axonics
- Baybe GmbH
- Blackrock Neurotech
- Brain Navi Biotechnology Co. Ltd
- Brainomix
- Cala
- DyAnsys
- Ethicon
- Helius Medical Technologies, Inc
- INBRAIN Neuroelectronics S.L
- Knight Therapeutics
- Medicrea
- Neiry
- Neumora Therapeutics, Inc
- Neurolief
- NeuroMetrix
- Obsidio, Inc
- Oticon Medical
- Pediatrix Therapeutics
- Precisis GmbH
- Processa Pharmaceuticals
- ReCor Medical
- Rune Labs
- Sinaptica Therapeutics, Inc.,
- SK Life Science, Inc
- Stimwave Technologies
- Sunovion Pharmaceuticals Inc.
- Takeda
- Theranica
- Tris Pharma, Inc
- Voyager Therapeutics
- American Chronic Pain Association
- Brain Injury Alliance of New Mexico
- Brain Injury Association of America
- Brazilian Neuromodulation Society
- Canadian Neuromodulation Society
- Centers for Disease Control and Prevention (CDC)
- Chinese Neuromodulation Society
- Defense Logistics Agency (DLA)
- European Brain Council
- European Centers for Disease Control and Prevention (ECDC)
- International Society for ECT and Neurostimulation
- Japan Society of Pain
- Latin America and the Caribbean Consortium on Dementia (LAC-CD)
- National Center for Biotechnology Information
- National Institute of Health (NIH)
- North America Neuromodulation Society
- Saudi Stroke Association
- South Africa Neuromodulation Society
- South African Spine Society
- Southern African Neuroscience Society (SANS)
- Spanish Pain Association
- The Japanese Society of Neuropathology
- The Neuromodulation Society of India
- The U.S. Food and Drug Administration (FDA)
- World Health Organization (WHO)